Sfoglia per AUTORE
KHANDANPOUR C
Collezione AOU Città della Salute di Torino
Items : 1
A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma. in EJHaem / EJHaem. 2024 Aug 1;5(5):940-950. doi: 10.1002/jha2.968. eCollection 2024 Oct.
2024
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Legenne P; Zitt C; Dawson KM; Stumpp MT; Suter C; Pour L; Iversen KF; Gamberi B; Khandanpour C; Vacca A; Jurczyszyn A; Trautmann-Grill K; Bringhen S; Grz??ko N; Szarejko M; Knop S; Stavropoulou V; Fey MF; Leupin N; Goldschmidt H;